{"id":164701,"title":"Cost-Effectiveness of Palivizumab Prophylaxis for Respiratory Syncytial Virus (RSV): A Systematic Review - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T14:19:22.080000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/cost-effectiveness-palivizumab-prophylaxis-respiratory-syncitial-virus.html?wbdisable=true","snippet":"Cost-Effectiveness of Palivizumab Prophylaxis for Respiratory Syncytial Virus (RSV): A Systematic Review - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu Jobs and the…","rawSnapshotUrl":"/api/snapshots/raw/164701","browseUrl":"https://replay.healtharchive.ca/job-1/20250418141922/https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/cost-effectiveness-palivizumab-prophylaxis-respiratory-syncitial-virus.html?wbdisable=true#ha_snapshot=164701","mimeType":"text/html","statusCode":200}